Max Health stock fell 2.55 percent as Q1 growth faced pressure

Published on 10/05/2026 at 22:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Max Health stock stood at INR 917 on October 5, 2026, down 2.55 percent on NSE. Q1 FY27 revenue rose 15.2 percent, while Anand Rathi kept its INR 1,220 target.

Max Health, INE027H01010, Illustration mit AI erstellt.

Max Health (ISIN INE027H01010) stock was last at INR 917 on the NSE on October 5, 2026, down 2.55 percent from the previous close. The latest reported quarter combined 15.2 percent revenue growth with pressure in oncology and a lower operating margin, giving investors a mixed operating picture.

Q1 revenue rose 15.2 percent

According to DSIJ on August 17, 2026, Max Healthcare reported Q1 FY27 consolidated revenue of INR 28.35 billion, up 15.2 percent year over year and 11.6 percent quarter over quarter. EBITDA rose 14.8 percent to INR 7.05 billion, while adjusted net profit increased 3.3 percent to INR 3.79 billion.

The operating detail matters because the EBITDA margin was 24.9 percent in Q1 FY27, compared with 26.8 percent in Q4 FY26. Occupancy stood at 75 percent, while average revenue per occupied bed increased 5 percent year over year to INR 81,900.

Capacity expansion meets oncology pressure

Oncology inpatient revenue accounted for 22 percent in Q1 FY27, down from 26 percent in Q1 FY26, according to DSIJ. The report linked the decline to the discontinuation of selected chemotherapy drugs for institutional patients, while also identifying price caps and team departures as risks.

Capacity additions provide the counterweight. Max Smart had 202 beds operational, with another 198 beds scheduled for commissioning in Q2 FY27, while the company approved INR 4.25 billion for a 202-bed brownfield tower at Max Super Speciality Hospital, Vaishali, according to DSIJ.

Max Healthcare's investor page describes a network of 21 healthcare facilities with more than 6,100 beds, alongside Max@Home and Max Lab. The company also lists June 30, 2026, as the latest quarterly results period on its financial-results page, Max Healthcare shows.

Stock stays near its yearly low

Max Health stock traded between INR 912 and INR 939.80 on October 5, 2026, with volume of 3,127,217 shares. Its 52-week range was INR 902.05 to INR 1,221.90, placing the latest price much nearer the yearly low than the high.

Valuation and execution therefore remain closely linked. Anand Rathi Research maintained its Buy rating and INR 1,220 target on August 17, 2026, while its report identified delayed projects, regulatory intervention and weaker international business as risks.

INR 917 price anchors the session

Max Health stock was last at INR 917 on the NSE on October 5, 2026, at 3:14 p.m. IST, with a market capitalization of INR 892.5 billion and a daily change of minus 2.55 percent.